Catalent At CPhI Worldwide 2014 - Module G - Biosimilars

Summary: Biosimilars,  are biologic medical products whose active drug substance is made by a living organism or derived from a living organism by means of recombinant DNA or controlled gene expression methods.

The 2014 Biosimilars preconnect module focused on competition with small molecules in the same indication, he path to successfully marketing a biosimilar product, beginning with a high performing technology platform and developments in global regulatory and agreements to get biosimilars to market.

Watch now: